Viatris' dividend yield is 4.93%, while Teva hasn't paid dividends since 2017. Thus, summing up this information, Viatris is ...
A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA ...
Secretary of Health and Human ServicesRobert F. Kennedy, Jr.is under constant siege. The political establishment that has ...
A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...
Professor from the Faculty of Medicine in Kragujevac Vladimir Jakovljevic said today that cooperation between Serbian and ...
Then, demand for its COVID-19 vaccine started to diminish. As hospitals resumed normal operations and anti-vaccine sentiment ...
The influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally.
Studies are sounding alarm bells regarding the safety of COVID-19 mRNA vaccines, particularly in light of new findings linking these injections to an increased risk of myocarditis, a potentially fatal ...
Scientists are designing mRNA vaccines to produce virus-like nanoparticles, which should lead to a more robust immune ...
Groundbreaking Study Raises Serious Concerns About COVID mRNA Vaccine Safety** A recent peer-reviewed study has emerged that scrutinizes the safety and implications of COVID-19 ...
A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...
The global mRNA therapeutics CDMO market size is calculated at USD 5.15 billion in 2025 and is expected to reach around USD 13.63 billion by 2034, growing at a CAGR of 11.37% for the forecasted period ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results